GSE86982 | GSM2317791 | Illumina HiSeq 2500 | Homo sapiens | 26Dp3_E02_smart-seq | cultured embryonic stem cells[DCX+][RM165049] | days in culture: 26; cre line: DCX+; differentiation#: RM165049; control: FALSE |
GSE86982 | GSM2318047 | Illumina HiSeq 2500 | Homo sapiens | 54Dn5_D11_smart-seq | cultured embryonic stem cells[DCX-][RM165048] | days in culture: 54; cre line: DCX-; differentiation#: RM165048; control: FALSE |
GSE86982 | GSM2318303 | Illumina HiSeq 2500 | Homo sapiens | SK_3_B11_smart-seq | cultured embryonic stem cells[RM165095][viral_barcoded] | days in culture: 54; differentiation#: RM165095; control: FALSE; viral barcoded: viral_barcoded |
GSE38495 | GSM967539 | Illumina Genome Analyzer IIx | Homo sapiens | Circulating melanoma cell HCT21031_CTC | NG2-sorted cell from blood | cell type: NG2-sorted cell from blood of melanoma patient |
GSE51254 | GSM1241169 | Illumina HiSeq 2000 | Homo sapiens | Single Cell C1 Microfluidics 16 | colon carcinoma HCT116 | cdna synthesis method: Clontech SMARTer; library construction method: Nextera (transposon); cell line: HCT116 |
GSE52529 | GSM1269106 | Illumina HiSeq 2500 | Homo sapiens | Cell T24_CT_E03 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 24; debris: FALSE; control well: FALSE; cells in well: 2; library protocol: Single-cell |
GSE57872 | GSM1395747 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH29_F01 | glioblastoma [Mes] | patient id: MGH29; cell type: Glioblastoma; subtype: Mes |
GSE57872 | GSM1396259 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_CSC8_H09 | gliomasphere CSC8 | cell line: CSC8; cell type: Gliomasphere Cell Line |
GSE64016 | GSM1562587 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.279 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
GSE64016 | GSM1562852 | Illumina HiSeq 2500 | Homo sapiens | G2_Exp1.074 | single H1-Fucci cell sorted from G2-M phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |